Author:
Lewin David A.,Weiner Michael P.
Subject
Drug Discovery,Pharmacology
Reference54 articles.
1. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework;Biomarkers Definitions Working Group;Clin. Pharmacol. Ther,2001
2. Clinical biomarkers in drug discovery and development;Frank;Nat. Rev. Drug Discov,2003
3. Prognostic significance of tumor oxygenation in humans;Evans;Cancer Lett,2003
4. An approach to the validation of markers for use in AIDS clinical trials;Mildvan;Clin. Infect. Dis,1997
5. Lesko, L. et al. (2003) Guidance for Industry: Pharmacogenomic Data Submissions. U.S. Department of Health and Human Services, Food and Drug Administration, CDER, CBER, CDRH. http://www.fda.gov/cder/guidance/5900dft.pdf
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献